Adipokine Chemerin Bridges Metabolic Dyslipidemia and Alveolar Bone Loss in Mice

被引:49
|
作者
Ramos-Junior, Erivan S. [1 ]
Leite, Gisele A. [2 ]
Carmo-Silva, Cecilia C. [1 ]
Taira, Thaise M. [2 ]
Neves, Karla B. [3 ]
Colon, David F. [3 ]
da Silva, Lea A. B. [2 ]
Salvador, Sergio L. [4 ]
Tostes, Rita C. [3 ]
Cunha, Fernando Q. [3 ]
Fukada, Sandra Y. [1 ]
机构
[1] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Pediat Dent, Sao Paulo, Brazil
[3] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil
[4] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Clin Analyses, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
ADIPOKINE; CHEMERIN; OSTEOCLASTS; METABOLISM; DYSLIPIDEMIA; OSTEOCLAST DIFFERENTIATION; RHEUMATOID-ARTHRITIS; INFLAMMATION; OBESITY; CELLS; RECEPTOR; DISEASE; CHEMR23; LIGAND; ADIPOGENESIS;
D O I
10.1002/jbmr.3072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chemerin is an adipokine that regulates adipogenesis and metabolic functions of mature adipocytes mainly through the activation of chemokine-like receptor 1 (CMKLR1). Elevated levels of chemerin have been found in individuals with obesity, type 2 diabetes, and osteoporosis. This adipokine was identified as an inflammatory and metabolic syndrome marker. Considering that the association between metabolic syndrome and bone health remains unclear, the present study aimed to clarify the role of chemerin in the pathophysiology of bone loss induced by dyslipidemia, particularly modulating osteoclastogenesis. In vitro analyses showed a downregulation of CMKLR1 at the early stage of differentiation and a gradual increase at late stages. Strikingly, chemerin did not modify osteoclast differentiation markers or osteoclast formation; however, it increased the actin-ring formation and bone resorption activity in mature osteoclasts. The increased bone resorption activity induced by chemerin was effectively inhibited by CMKLR1 antagonist (CCX832). Chemerin boosting mature osteoclast activity involves ERK5 phosphorylation. Moreover, two models of dyslipidemia (high-fat diet [HFD]-treated C57/BL6 and db/db mice) exhibited significantly increased level of chemerin in the serum and gingival tissue. Morphometric analysis showed that HFD-treated and db/db mice exhibited increased alveolar bone loss compared to respective control mice, which was associated with an up-regulation of chemerin, CMKLR1 and cathepsin K mRNA expression in the gingival tissue. The treatment of db/db mice with CCX832 effectively inhibited bone loss. Antagonism of chemerin receptor also inhibited the expression of cathepsin K in the gingival tissue. Our results show that chemerin not only increases osteoclasts activity in vitro, but also that increased level of chemerin in dyslipidemic mice plays a critical role in bone homeostasis. (c) 2016 American Society for Bone and Mineral Research.
引用
收藏
页码:974 / 984
页数:11
相关论文
共 50 条
  • [21] ALVEOLAR BONE LOSS
    DYER, MRY
    JOURNAL OF DENTAL RESEARCH, 1972, 51 (05) : 1248 - &
  • [22] Development of an Enzyme-Linked Immunosorbent Assay (ELISA) for a Novel Adipokine Chemerin in Mice
    Rose, Tina
    Mistry, Jehangir
    Xiao, Qiang
    OBESITY, 2008, 16 : S100 - S101
  • [23] Loss of Dkk-1 in Osteocytes Mitigates Alveolar Bone Loss in Mice With Periodontitis
    Goes, Paula
    Dutra, Caio
    Loesser, Lennart
    Hofbauer, Lorenz C.
    Rauner, Martina
    Thiele, Sylvia
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [24] CYLD inhibits osteoclastogenesis to ameliorate alveolar bone loss in mice with periodontitis
    Cao, Yuxin
    Zhang, Xinming
    Hu, Meilin
    Yang, Song
    Li, Xiaoyan
    Han, Ruohui
    Zhou, Jun
    Li, Dengwen
    Liu, Dayong
    JOURNAL OF CELLULAR PHYSIOLOGY, 2023, 238 (05) : 1036 - 1045
  • [25] Heterogeneity of Porphyromonas gingivalis strains in the induction of alveolar bone loss in mice
    Baker, PJ
    Dixon, M
    Evans, RT
    Roopenian, DC
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 2000, 15 (01): : 27 - 32
  • [26] Alveolar Bone Loss: A Shorter-Time Study Model in Mice
    Alencar, Cristiane
    Pereira Padilha, Dalva Maria
    Hilgert, Juliana Balbinot
    Rivaldo, Elken Gomes
    SCANDINAVIAN JOURNAL OF LABORATORY ANIMAL SCIENCE, 2010, 37 (01) : 5 - 9
  • [27] Local administration of ReveromycinA ointment suppressed alveolar bone loss in mice
    Miyazawa, Ken
    Asano, Yuichiro
    Tabuchi, Masako
    Kako, Shunsuke
    Kawatani, Makoto
    Osada, Hiroyuki
    Maeda, Hatsuhiko
    Goto, Shigemi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2021, 147 (01) : 40 - 47
  • [28] Accelerated alveolar bone loss in mice lacking interleukin-10
    Al-Rasheed, A
    Scheerens, H
    Rennick, DM
    Fletcher, HM
    Tatakis, DN
    JOURNAL OF DENTAL RESEARCH, 2003, 82 (08) : 632 - 635
  • [29] Loss of chemerin triggers bone remodeling in vivo and in vitro
    Han, Long
    Zhang, Yu
    Wan, Shiwei
    Wei, Qingbo
    Shang, Wenbing
    Huang, Guichen
    Fang, Penghua
    Min, Wen
    MOLECULAR METABOLISM, 2021, 53
  • [30] ALVEOLAR BONE LOSS AND CAPILLAROPATHY
    BARRETT, RA
    CHERASKIN, E
    RINGSDORF, WM
    JOURNAL OF PERIODONTOLOGY, 1969, 40 (03) : 131 - +